RE: Abingdon/MHRA clause28 Dec 2020 11:16
Twatcher...it almost reads as though you've sold up.
https://webcasting.brrmedia.co.uk/broadcast/5fbf9d78b19325729a9d7d05/5fc522050c7aa22257c26c99
13'54" seconds in, Colin starts talking about antibody testing;
"with the positive news of vaccine deployment, we expect that antibody tests will playa significant and key role in confirming if the vaccine has been effective"
There was also the much hyped publication from CIGA, on twitter, that was later taken down. I do think the statement used was excessive... BUT.. it was also somewhat reminiscent of the time BBI "leaked" the news of the "first" RTC order.
In addition, the MHRA break clause... As Satellite has mentioned, the term "may" was used. Standard terms.
There are a lot of complications in working with the UK government. I'm sure Colin has some tails to tell, already.
My position...
If we don't sell many ABC-19 to the UK gov.. great. We get more money selling the same test to other parties.
We have only allocated 200k per week to ABC-19 production, which can be flex'd to produce other tests as needed.
We get more profit from other tests (Antigen, Visitect AB), which is why Colin and team have allocated more capacity to those.
Colin and team have, and continue, to deliver on the strategy set out months ago. It literally is a tick box exercise, for an investor, with risk reducing with each tick against milestones being met.
Omega speak with Abingdon, Mologic, and the UK gov, and 75+ countries, more than I do... I'm going to hazard a guess they know more than any poster on this BB, so I'm going to trust them to continue delivering.
Sign In
Follow the stocks
